Proteomics analysis after traumatic brain injury in rats: The search for potential biomarkers;Análise proteômica após lesáo cerebral traumática em ratos: A busca por biomarcadores

Arquivos de Neuro-Psiquiatria

Volumn 73, Issue 4, 2015, Pages 342-349

  Ding, Jun ^a   Ding, Zhen Gang ^b   Yuan, Fang ^a   Guo, Jian Yi ^a   Chen, Hao ^a   Gao, Wen Wei ^a   Wang, Ren ^a   Gu, Yi ^a   Chen, Jiong ^a   Guo, Yan ^a   Tian, Heng Li ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b Department of Neurosurgery   (China)

Author keywords

Biomarkers; Mass spectrometry; Proteomics; Traumatic brain injury; Two dimensional gel electrophoresis

Indexed keywords

14 3 3 PROTEIN ZETA; ABC TRANSPORTER; BETA TUBULIN; BIOCHEMICAL MARKER; FODRIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN ZETA CHAIN; LEKR1 PROTEIN; M2 PYRUVATE KINASE; MICROTUBULE ASSOCIATED PROTEIN 2; NEBULIN; NEURON SPECIFIC ENOLASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN; PROTEIN S100B; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RAN PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; THYROID HORMONE RECEPTOR; TRANSFER RNA METHYLTRANSFERASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; BIOLOGICAL MARKER;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PH; PROTEIN EXPRESSION; PROTEOMICS; RAT; TRAUMATIC BRAIN INJURY; TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL; BRAIN CHEMISTRY; BRAIN INJURIES; CHEMISTRY; DISEASE MODEL; MASS SPECTROMETRY; METABOLISM; PROGNOSIS; RANDOMIZATION; REFERENCE VALUE; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MALE; MASS SPECTROMETRY; PROGNOSIS; PROTEOMICS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; TIME FACTORS;

EID: 84929305718     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20150006     Document Type: Article

References (29)

1. Chiu WT, Huang SJ, Tsai SH, Lin JW, Tsai MD, Lin TJ et al. The impact of time, legislation, and geography on the epidemiology of traumatic brain injury. J Clin Neurosci. 2007;14(10):930-5. http://dx.doi.org/10.10167j.jocn.2006.08.004
2. Centers for Disease Control and Prevention. TBI outcomes and consequences. [Cited 2005 July]. Available from: http://www.cdc.gov/node.do/id/0900f3ec8000dbdc/aspectId/A0400027
3. Hergenroeder GW, Redell JB, Moore AN, Dash PK. Biomarkers in the clinical diagnosis and management of traumatic brain injury. Mol Diagn Ther 2008;12(6):345-58. http://dx.doi.org/10.2165/1250444-200812060-00002
4. Bazarian JJ, Zemlan FP, Mookerjee S, Stigbrand T. Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Inj 2006;20(7):759-65.
5. Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotraum. 2007;24(12):1793-801. http://dx.doi.org/10.1089/neu.2007.031
6. Sun W, Xing B, Sun Y, Du X, Lu M, Hao C et al. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics. 2007;6(10):1798-808.
7. Ottens AK, Kobeissy FH, Fuller BF, Liu MC, Oli MW, Hayes RL et al. Novel neuroproteomic approaches to studying traumatic brain injury. Prog Brain Res. 2007;161:401-418. http://dx.doi.org/10.1016/S0079-6123(06)61029-7
8. Finnie JW. Animal models of traumatic brain injury: a review. Aust Vet J. 2001;79(9):628-33. http://dx.doi.org/10.1111/j.1751-0813.2001.tb10785.x
9. Sullivan PG, Keller JN, Bussen WL, Scheff SW. Cytochrome c release and caspase activation after traumatic brain injury. Brain Res. 2002; 949(1 2):88-96. http://dx.doi.org/10.1016/S0006-8993(02)02968-2
10. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA et al. Neuron-specific enolase, and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics. 2002;109(2):E31.
11. Bohmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP et al. Fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurg. 2011;68(6):1624-1631. http://dx.doi.org/10.1227/NEU.0b013e318214a81f
12. Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, Romaschin A et al. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. J Trauma. 2011;71(5 Suppl 1):S478-86. http://dx.doi.org/10.1097/TA.0b013e318232fa70
13. Stein DM, Lindell AL, Murdock KR, Kufera JA, Menaker J, Bochicchio GV et al. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury. J Neurotrauma. 2012;29(6):140-149. http://dx.doi.org/10.1089/neu.2011.2149
14. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe, A, Redl H. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma. 2004;21(11):1553-61. http://dx.doi.org/10.1159/000103304
15. Piazza O, Storti MP, Cotena S, Stoppa F, Perrotta D, Esposito G et al. S100B is not a reliable prognostic index in paediatric TBI. Pediatr. Neurosurg. 2007;43(4):258-64.
16. Aikmana J, O'Steen B, Silver X, Torres R, Boslaugh S, Blackband S et al. Alpha-II-spectrin after controlled cortical impact in the immature rat brain. Dev Neurosci. 2006;28(4 5):457-465. http://dx.doi.org/10.1159/000094171
17. Brophy GM, Pineda JA, Papa L, Lewis SB, Valadka AB, Hannay HJ et al. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J Neurotraum. 2009;26(4):471-9. http://dx.doi.org/10.1089/neu.2008.0657
18. Berger RP, Hayes R, Richichi R, Beers SR, Wang KK. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and alII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. J Neurotrauma. 2012;29(1):162-7. http://dx.doi.org/10.1089/neu.2011.1989
19. Park D, Joo SS, Lee HJ, Choi KC, Kim SU, Kim YB. Microtubule-associated protein 2, an early blood marker of ischemic brain injury. J Neurosci Res. 2012;90(2):461-7. http://dx.doi.org/10.1002/jnr.22769
20. Barberan S, McNair K, Iqbal K, Smith NC, Prendergast GC, Stone TW et al. Altered apoptotic responses in neurons lacking RhoB GTPase. Eur J Neurosci. 2011;34(11):1737-46. http://dx.doi.org/10.1111/j.1460-9568.2011.07891.x
21. Tisdale EJ. Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Ciota /lambda and plays a role in microtubule dynamics in the early secretory pathway. J Biol Chem. 2002;277(5):3334-41. http://dx.doi.org/10.1074/jbc.M109744200
22. Christofk HR, Heiden MG, Wu N, Asara JM, Cantley LC. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature. 2008;452(7184):181-6. http://dx.doi.org/10.1038/nature06667
23. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145(5):732-744. http://dx.doi.org/10.1016/j.cell.2011.03.054
24. Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 2011;334(6060):1278-83. http://dx.doi.org/10.1126/science.1211485
25. Bera TK, Iavarone C, Kumar V, Lee S, Lee B, Pastan I. MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proc Natl Acad Sci USA. 2002;99(10):6997-7002. http://dx.doi.org/10.1073/pnas.102187299
26. Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z et al. Endothelial sulfonylurea receptor 1- regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest. 2007;117(8):2105-13. http://dx.doi.org/10.1172/JCI32041
27. Bersano A, Fiorini M, Allaria S, Zanusso G, Fasoli E, Gelati M et al. Detection of CSF 14-3-3 protein in Guillain-Barré syndrome. Neurology. 2006;67(12):1-6. http://dx.doi.org/10.1212/01.wnl.0000249150.98891.d1
28. Namikawa K, Su Q, Kiryu-Seo S, Kiyama H. Enhanced expression of 14-3-3 family members in injured motoneurons. Brain Res Mol Brain Res. 1998;55(2):315-320. http://dx.doi.org/10.1016/S0169-328X(98)00012-6
29. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB et al. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell. 2000;6(1):41-51. http://dx.doi.org/10.1016/S1097-2765(00)00006-X